The safety and efficacy of tolvaptan in the treatment of patients with autosomal dominant polycystic kidney disease: A systematic review and meta-analysis Xuanwei Li, Wenlai Li, Yue Li, Chuanjiang Dong, Ping Zhu

Autosomal dominant polycystic kidney disease V. E. TORRES , P. C. HARRIS

The E23K polymorphism of the KCNJ11gene is associated with lower insulin release in patients with Autosomal Dominant Polycystic Kidney Disease Maria Pietrzak-Nowacka, Krzysztof Safranow, Agnieszka Binczak-Kuleta, Leszek Domanski, Andrzej Ciechanowicz, Kazimierz Ciechanowski